Does CANRENOATE Cause Off label use? 45 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 45 reports of Off label use have been filed in association with CANRENOATE. This represents 10.2% of all adverse event reports for CANRENOATE.
45
Reports of Off label use with CANRENOATE
10.2%
of all CANRENOATE reports
1
Deaths
12
Hospitalizations
How Dangerous Is Off label use From CANRENOATE?
Of the 45 reports, 1 (2.2%) resulted in death, 12 (26.7%) required hospitalization, and 2 (4.4%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CANRENOATE. However, 45 reports have been filed with the FAERS database.
What Other Side Effects Does CANRENOATE Cause?
Hyperkalaemia (96)
Acute kidney injury (63)
Toxic epidermal necrolysis (58)
Hyponatraemia (52)
Dehydration (39)
Hypotension (39)
Drug hypersensitivity (37)
Dyspnoea (36)
Asthenia (33)
Bradycardia (26)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which CANRENOATE Alternatives Have Lower Off label use Risk?
CANRENOATE vs CANRENOIC ACID
CANRENOATE vs CANRENONE
CANRENOATE vs CANTHARIDIN
CANRENOATE vs CAPECITABINE
CANRENOATE vs CAPIVASERTIB